Cargando…
New modalities of cancer treatment for NSCLC: focus on immunotherapy
Recent advances in the understanding of immunology and antitumor immune responses have led to the development of new immunotherapies, including vaccination approaches and monoclonal antibodies that inhibit immune checkpoint pathways. These strategies have shown activity in melanoma and are now being...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917949/ https://www.ncbi.nlm.nih.gov/pubmed/24520205 http://dx.doi.org/10.2147/CMAR.S57550 |